Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Legalon SIL rescue therapy in hepatitis C incomplete responders
2013-000245-39Phase 2Terminated
- Sponsor
- Rottapharm Biotech
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Legalon SIL in hepatitis C virus infection (2 arms), sponsored by Rottapharm Biotech. Primary endpoint: Complete virological response at end of treatment. Started Jun 2013; status: terminated.
02
Drugs
Legalon SIL
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2013-000245-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000245-39.